|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| |
Abstract |
|---|
|
|
|---|
Polycyclic aromatic hydrocarbons (PAHs) increase cytosolic Ca2+ concentration ([Ca2+]i) in lymphocytes and mammary epithelial cells, but little is known regarding their effects on [Ca2+]i in airway epithelium. We hypothesized that benzo[a]pyrene (BP) and/or anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE), a carcinogenic BP metabolite, increases [Ca2+]i in untransformed human small airway epithelial (SAE) cells and that their effects on [Ca2+]i are directly proportional to carcinogenicity. SAE [Ca2+]i was determined by a ratiometric digital Ca2+ imaging system. BPDE increased SAE [Ca2+]i within 20 s in media with high (1 mM) and low (10 nM) Ca2+ at a threshold concentration of 0.2 nM. Elevation of [Ca2+]i persisted longer with high Ca2+. Neither BP nor solvent altered [Ca2+]i. Thapsigargin and inositol 1,4,5- phosphate receptor (InsP3R) antagonists inhibited this BPDE action with low Ca2+. We conclude that BPDE but not BP increases [Ca2+]i partly by mobilizing Ca2+ from cytosolic stores through an InsP3R. The most potent carcinogenic PAH diol epoxide increased in SAE [Ca2+]i at the lowest threshold concentration, suggesting that carcinogenicity is directly proportional to the action of PAHs on SAE [Ca2+]i. Short-term exposure to BPDE 36 to 48 h before the study rendered SAE cells less sensitive to BPDE, suggesting that BPDE may also induce persistent changes in Ca2+ signaling pathways.
| |
Introduction |
|---|
|
|
|---|
The human lung is exposed to various carcinogenic and noncarcinogenic polycyclic aromatic hydrocarbons (PAHs) derived from cigarette smoke, air pollutants, and dietary components. Carcinogenic actions of benzo[a]pyrene (BP), a tobacco-derived PAH, have been attributed to anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene (BPDE), a BP metabolite (1, 2). BPDE is thought to exert a genotoxic effect on DNA by forming guanine adducts because the identical DNA adduct formation was observed in rodent lungs treated with BP (3). Other carcinogenic PAH diol epoxides also form guanine adducts (1, 2, 4). Although genotoxic effects of PAHs play an important role in tumor initiation, PAHs also potentiate tumor promotion and progression in rodent models (5). The mechanisms whereby BP and other PAHs promote tumorigenesis are less well understood.
Tumorigenesis requires mutations in key regulatory genes involved in cell death, differentiation, and proliferation. The signaling pathways associated with cell proliferation and death involve intracellular Ca2+ signaling that is often altered during tumorigenesis. For example, transformed tumor cell lines became resistant to the apoptotic stimuli of an increase in cytosolic Ca2+ concentration ([Ca2+]i ) (6). It was reported that PAHs increased [Ca2+]i, in part, through mobilization of Ca2+ from cytosolic Ca2+ stores in both human lymphocytes (7) and primary human mammary epithelial cells (10). However, the precise mechanisms of their action on [Ca2+] are virtually unknown because these studies were performed using flow cytometry in cell aggregates and hence the effects of PAH on single-cell [Ca2+]i over time were not addressed. Moreover, there is no data on the effects of PAHs on airway epithelial cell [Ca2+]i, the cells that are most frequently exposed to PAH.
The ability to culture primary human small airway epithelial (SAE) cells (Clonetics, San Diego, CA) and maintain them in culture enabled us to determine the effects of BPDE on SAE cells. Previously, we demonstrated that the cytotoxic effects of BPDE were much greater in SAE cells than in A549 human lung cancer cells (11). More importantly, at noncytotoxic concentrations (1 to 10 nM), BPDE prevented serum-induced SAE cell differentiation into nonciliated epithelial cells, and this BPDE action was mediated through Ras signaling pathways (11). Because Ca2+ signaling pathways are crucial in cell proliferation, differentiation, and death, we hypothesized that: (1) BPDE increases SAE [Ca2+]i, and (2) tumorigenicity of PAH diol epoxides is proportional to the effects on SAE [Ca2+]i.
To test our hypotheses, we used dynamic calcium imaging and determined the effects of PAH diol epoxides on subconfluent monolayers of SAE cells. We also determined whether prior exposure of BPDE affects the acute effects of BPDE on SAE [Ca2+]i.
| |
Materials and Methods |
|---|
|
|
|---|
Analytical Methods
Cell cultures. SAE cells were maintained in a serum-free SAE basal medium (CCMD 160; Clonetics) supplemented with growth factors (11). The medium was changed every 2 d. SAE cells were passaged when confluent (once per week). All the experiments were conducted using cells at less than five passages. SAE cells were passaged by treating cells with trypsin (0.25 g/liter) and ethylenediaminetetraacetic acid (0.1 mg/ml) in Hanks' balanced salt solution (11). SAE cells were grown on 25-mm2 glass coverslips placed in a 35 × 35 mm petri dish by seeding 3 × 103 cells/ml.
Measurement of [Ca2+]i. Cells were loaded with 5 nM of the
Ca2+-sensitive fluorophore fura-2-AM (the acetoxymethyl derivative of fura-2; Molecular Probes, Eugene, OR) plus 0.2 µg/ml pluronic acid (Molecular Probes) for 15 min at room temperature in
a Ca2+ free solution (RPMI 1640) (12, 13). Cells were then bathed in calcium-containing recording solution (RPMI 1640 with 1 mM CaCl2) for 20 min before the start of each experiment to prevent depletion of cytosolic Ca2+ stores. The coverslip was then placed
in a metal holder on the stage of an inverted microscope (Nikon
Eclipse TE200). Cells were then treated with BPDE in either
low- or high-Ca2+ medium. Given the short duration of exposure
to low-concentration calcium-containing solution, there was no
effect on basal levels of SAE [Ca2+]i. Ratiometric imaging was
performed using excitation wavelengths of 340 and 380 nm and
emission wavelength of 560 nm. Images were recorded with an
extended ISIS intensified ICCD camera from Photonic Science
(Robertsbridge, UK) using Axon Instruments (Foster City, CA)
image capture and analysis software. Calcium calibration was achieved by measuring a maximum (with 50 nM ionomycin) and
a minimum (with 5 mM ethyleneglycol-bis-(
-aminoethyl ether)-
N,N'-tetraacetic acid [EGTA]) for each cell, assuming the dissociation constant (Kd) of 224 (12). Measurement was done in the
area containing 3 or 4 cells. [Ca2+]i was calculated using the following equation; [Ca2+]i = Kd [(R
Rmin)/(Rmax
R)]Sf2/Sb2
(12); where R is the 340/380 excitation ratio of the sample; Rmax
was calculated after permeabilizing the cells with 50 nM ionomycin and represents maximal [Ca2+]i; Rmin was obtained using 5 mM
EGTA and is the minimal [Ca2+]i; Sf2 is the maximum 380-nm signal intensity; and Sb2 is the minimum 380-nm signal intensity (12).
Reagents
BPDE, anti-1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-5-methylchrysene (5MeCDE), anti-1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-6-methylchrysene (6MeCDE), and anti-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene (BcPDE) were gifts
from Dr. Shanto Amin (American Health Foundation, Valhalla,
NY) and Stephen S. Hecht (University of Minnesota Cancer Center, Minneapolis, MN). These compounds are all racemic
forms (purity > 99%). They were dissolved in dimethyl sulfoxide
(DMSO), aliquotted, and kept at
20°C until the time of the experiments. BcPDE is a fjord region diol epoxide in which the
benzylic carbon of the epoxide ring is located in a sterically congested four-sided fjord region (14, 15). BcPDE is one of the most
potent carcinogenic PAH diol epoxides tested in rodents (15).
5MeCDE has a sterically hindered bay region; its carcinogenicity
is similar to that of BPDE (16). 6MeCDE is structurally related
to 5MeCDE without a hindered bay region, and its carcinogenicity in rodents is less than those of the other PAH diol epoxides
used in this study (16). The final concentration of DMSO in the
SAE cell cultures was < 0.5%. The DMSO used for dissolving
PAH diol epoxides did not affect cell viability, proliferation, or
apoptotic changes in our culture system (11). BP (Aldrich, Milwaukee, WI), thapsigargin (Molecular Probes), ryanodine (Molecular Probes), 2-aminoethosydiphenyl borate (2-APB; Calbiochem-Novabiochem, La Jolla, CA), and xestospongin C (Xest C) were
dissolved into DMSO, aliquotted, and kept at
20°C.
Experimental Design
Exp. 1: BPDE induced increase in SAE [Ca2+]i. Fura-2-loaded SAE cells were treated with BPDE at a starting concentration of 0.05 nM in a medium with 1 or 10 nM Ca2+. If there was no change for 100 s, cells were treated with BPDE at the doubling concentrations until > 10-fold increase in SAE [Ca2+]i was seen. This concentration was defined as the threshold BPDE concentration for changes in SAE [Ca2+]i. Duration of SAE [Ca2+]i change was also determined. We defined the duration of SAE [Ca2+]i as time required for SAE [Ca2+]i to return to < 10% above the baseline [Ca2+]i. To determine whether BPDE caused Ca2+ mobilization from intracellular Ca2+ stores, a low-Ca2+ (10 nM) medium and a medium without Ca2+ were used. We also examined the effects of BP, a parent PAH of BPDE, on SAE [Ca2+]i at concentrations of 0.05 to 2 nM. This was to determine whether binding to arylhydrocarbon receptor (AhR) ligand by BPDE and BP is associated with their actions on [Ca2+]i, inasmuch as both compounds have equivalent affinity to AhR ligand (5). Lastly, to determine the subcellular mechanisms whereby BPDE increased SAE [Ca2+]i, SAE cells were treated with either thapsigargin, an inhibitor of Ca-adenosine triphosphatase (ATPase) (6); ryanodine, a plant alkaloid that causes release of calcium from specific intracellular stores through ryanodine receptor (RyR) (17); and inhibitors of inositol 1,4,5-triphosphate receptor (InsP3R) (2-APB or Xest-C) (18) before treatment with BPDE. In these experiments, the total amount of BPDE stock solution added to the chamber (volume; 1.5 ml) was less than 7.5 µl. Vehicle controls (DMSO) were performed for each experimental protocol.
Exp. 2: Effects of other carcinogenic PAH diol epoxides on SAE [Ca2+]i. The sensitivity of SAE [Ca2+]i to other carcinogenic PAH diol epoxides was determined. PAH diol epoxides tested included BcPDE, 5MeCDE, and 6MeCDE. These PAH diol epoxides were added to the medium at a starting concentration of 0.033 nM. The threshold concentration on SAE [Ca2+]i was determined as described in Exp. 1 in media with high (1 mM) and low (10 nM) Ca2+. Vehicle controls (DMSO) were performed for each compound.
Exp. 3: Effects of prior BPDE exposure on the acute effect of BPDE on SAE [Ca2+]i. SAE cells at 50 to 60% confluence (usually 4 d after subcultivation) were treated with BPDE (1 nM) or control vehicle (DMSO) in SAE cell medium (low Ca2+, 4 nM) for 1 h. The medium was changed, and cells were then cultured for an additional 36 to 48 h. We chose to use this time point secondary to good cell viability. At the end of culture, BPDE threshold concentration that caused an increase in SAE [Ca2+]i was determined in both low (10 nM)- and high (1 mM)-Ca2+ media as described in Exp. 1. We chose to treat SAE cells with 1 nM BPDE because this BPDE dose was not toxic but significantly altered serum-induced SAE cell differentiation (11).
Statistics
For comparison of test values with control values, the Mann-Whitney test or Chi-Square test was used. A value of P < 0.05 was considered significant.
| |
Results |
|---|
|
|
|---|
Effects of BPDE on SAE Cell [Ca2+]i
The first part of the experiments was done to determine whether BPDE affects SAE [Ca2+]i by affecting cytosolic Ca2+ mobilization and/or extracellular Ca2+ influx. BPDE (0.2 to 2 nM) increased SAE [Ca2+]i in both low (10 nM)- and high (1 mM)-Ca2+ media (Figures 1 and 2) within 20 s. The threshold concentration of BPDE was 0.2 nM (Figures 1 and 2). The duration of [Ca2+]i changes induced by BPDE was greater in a high-Ca2+ medium (Figures 1 and 2). BP, a parent PAH of BPDE, did not affect SAE [Ca2+]i at concentrations of 0.2 to 2 nM (Figure 1). Thapsigargin (50 nM), which depletes cytosolic Ca2+ stores, abolished the effects of BPDE in a low-Ca2+ medium but not in a high-Ca2+ medium (Figure 3). To determine the mechanisms of BPDE action on [Ca2+]i, we tested the effects of ryanodine that induce Ca2+ release from cytoslic stores through RyR and the effects of selective inhibitors of InsP3R. Neither baseline SAE [Ca2+]i nor the BPDE action on [Ca2+]i was altered by ryanodine (1 to 50 µM) (Figure 4). In contrast, 2-APB (25 to 50 µM), an inhibitor of InsP3R-gated Ca channel, abolished the BPDE action in a low-Ca2+ medium (Figure 5). Xest-C (5 µM), another InsP3R inhibitor, inhibited the acute BPDE action on SAE [Ca2+]i when cells were pretreated with Xest-C for 15 min (data not shown).
|
|
|
|
|
Effects of BcPDE, 5MeCDE, and 6MeCDE on SAE Cell [Ca2+]i
All the carcinogenic PAH diol epoxides tested increased SAE [Ca2+]i in high (1 mM)- and low (10 nM)-Ca2+ media (Figure 6). The threshold concentrations on SAE cell [Ca2+]i were 0.067 nM for BcPDE (a most potent carcinogenic PAH diol epoxide in rodents), 0.2 nM for 5MeCDE, and 0.4 nM for 6MeCDE (a least potent carcinogen among PAH diol epoxides tested) (Figure 6). The duration of SAE [Ca2+]i changes was greater in a high-Ca2+ medium but did not differ among carcinogenic PAH diol epoxides tested.
|
Effects of Short-Term Prior Exposure of BPDE on the BPDE Action on SAE [Ca2+]i
Short-term (1-h) exposure of SAE cells with BPDE (1 nM) 36 to 48 h before the experiment did not alter the baseline SAE [Ca2+]i. However, SAE cells became less sensitive to the acute action of BPDE on SAE [Ca2+]i, requiring 323 ± 108 and 282 ± 105% higher threshold concentrations in high- and low-Ca2+ media, respectively (Figure 7). This decrease in sensitivity to BPDE was observed up to 96 h after BPDE exposure; we were unable to determine SAE cell sensitivity to BPDE beyond that time period due to declining SAE cell viability. Such BPDE action was not observed when SAE cells were pretreated at BPDE concentrations of 0.1 to 0.5 nM. Short-term prior exposure of control vehicle (DMSO) did not alter the BPDE action on SAE [Ca2+]i; all the cells tested increased [Ca2+]i at a BPDE concentration of 0.2 nM. In addition, as opposed to the acute effects of BPDE on [Ca2+]i, the presence of 2-APB during prior treatment of BPDE did not prevent decreased SAE cell sensitivity to BPDE 36 to 48 h after BPDE treatment.
|
| |
Discussion |
|---|
|
|
|---|
Although the mechanisms whereby PAH exposure causes lung cancer remain poorly defined, the present study provides data that BPDE, a major tobacco-derived carcinogen, acutely increases [Ca2+]i in untransformed human SAE cells at a threshold concentration of 0.2 nM. Further evidence that elevation in SAE [Ca2+]i plays a role in carcinogenesis derives from the observation that the effects of carcinogenic PAH diol epoxides on SAE [Ca2+]i are directly proportional to the ability of these compounds to induce tumors in rodents. The most potent carcinogenic PAH diol epoxide tested caused an increase in SAE [Ca2+]i at the lowest threshold concentration. Short-term prior exposure of BPDE rendered SAE cells less sensitive to the acute action of BPDE on SAE [Ca2+]i. This is the first report revealing the direct effects of BPDE on cellular functions in normal human lung cells, suggesting that short-term exposure of SAE cells to BPDE exerts a prolonged effect on intracellular SAE cell calcium homeostasis.
To determine the subcellular mechanism whereby BPDE causes an elevation in SAE [Ca2+]i, SAE cells were treated with BPDE in both high and low Ca2+. Because the extracellular calcium had no effect on the response of SAE cells to BPDE, influx of extracellular calcium is not the primary source of the BPDE-induced transient change in SAE [Ca2+]i. The observation that thapsigargin, an inhibitor of Ca-ATPase activity in the endoplasmic reticulum (ER), blocked the effects of BPDE on SAE [Ca2+]i indicates that BPDE causes calcium release from the ER. Because ryanodine, a plant alkaloid that causes release of intracellular calcium stores through a RyR (17), had no effect on either baseline SAE [Ca2+]i or BPDE-induced changes in SAE [Ca2+]i, we conclude that calcium release from the ryanodine-sensitive stores does not play a role in the BPDE- induced increase in [Ca2+]i. In contrast, InsP3R blockade with 2-APB and Xest-C (18) abolished the BPDE-induced increase in SAE [Ca2+]i. Taken together, these findings indicate that BPDE induces transient Ca2+ release from InsP3-sensitive intracellular stores via InsP3-gated Ca2+ channels (18).
Carcinogenic PAH diol epoxides examined in this study include BcPDE (a fjord region diol epoxide), 5MeCDE (a hindered bay-region diol epoxide), and 6MeCDE. One of the striking findings is that the effects of these PAH diol epoxides on SAE [Ca2+]i were directly proportional to their tumorigenicity observed in rodents and the potency of these PAH diol epoxides on guanine adduct formation (4, 14). BcPDE, one of the most potent carcinogenic PAH diol epoxides (14), altered SAE [Ca2+]i at the lowest threshold concentration of 0.067 nM. 6MeCDE differs from 5MeCDE at only a single methylation site, but has less tumorigenicity in rodents than either 5MeCDE or BPDE (16). 6MeCDE had the highest threshold concentration at 0.4 nM on SAE [Ca2+]i. These concentrations of PAH diol epoxides are attainable in vivo (5). These findings indicate that the effects of PAH diol epoxides on SAE [Ca2+]i can theoretically play a role in tumorigenesis caused by PAH diol epoxides.
Although the present study did not identify the receptors that cause the effects of PAH diol epoxides on SAE cells, our data indicate that BPDE may increase SAE [Ca2+]i through binding a cytosolic AhR ligand. However, PAHs and PAH diol epoxides bind to AhR ligand at equal affinity. If BPDE acts through binding of the 95-kD ligand that binds to a subunit of AhR in the cytosol (9), both BPDE and BP should cause an elevation in SAE [Ca2+]i. However, BP, a parent PAH of BPDE, did not alter [Ca2+]i in SAE cells. It is thus unlikely that BPDE increases SAE [Ca2+]i through binding to a cytosolic AhR ligand.
To determine whether prior exposure to BPDE might affect calcium homeostasis of airway epithelial cells, we treated SAE cells with BPDE after exposure to BPDE (< 1 h). Despite the fact that prior exposure occurred more than 36 h before the study, we found that SAE cell sensitivity to the BPDE-induced increase in [Ca2+]i was significantly attenuated. The half-life of BPDE is very short and BPDE per se is very unlikely to occupy any ligand sites more than 10 min (21). Thus, if we observed any significant changes they may more likely be due to the DNA/RNA/protein adduct formation caused by BPDE and not associated with acute change in [Ca2+]i through InsP3R. This assumption is consistent with our finding that 2-APB failed to prevent this BPDE action. Moreover, this possibility is further supported by our recent preliminary finding that the prior BPDE exposure also affects sensitivity to reagents (adenosine triphosphate and acetylcholine) that exert their actions through InsP3R (unpublished observations). Such BPDE action may have an implication for BPDE tumorigenicity because Ca2+ signaling pathways are often altered in tumor cells, rendering them less sensitive to external growth/apoptotic signals (6). Previously, we observed that prior short-term exposure of BPDE prevented serum-induced SAE cell differentiation into nonciliated epithelial cells and that this was partially blocked by inhibitors of phosphatidylinositol (PI)-3K and extracellular regulated kinase (Erk)1/Erk2 (11). Given the close relationship between Ca2+ signaling pathways and PI-3K and Erk1/Erk2 activation, the BPDE action on SAE [Ca2+]i may be associated with the BPDE inhibitory action on SAE cell differentiation (11). Further study of this aspect will be important for addressing the effects of BPDE on tumor promotion.
Our findings raise an important question of how the BPDE action on SAE [Ca2+]i affects SAE cell functions and/or homeostasis in association with its tumorigenicity. BPDE is thought to induce lung tumorigenesis in A/J mice, exerting actions on K-ras oncogene and Ras-mediated signaling pathways that are activated by external growth factors (22). We also observed recently that BPDE activates Erk1/Erk2, downstream protein kinases of Ras-mediated signaling pathways in SAE cells (unpublished observations). Intracellular Ca2+ signaling is closely associated with PI-3K and Ras-mediated signaling pathways (26, 27). Our results suggest that the BPDE action on [Ca2+]i could lead to activation of Ras-mediated signaling pathways and resultant change in cellular homeostasis.
In summary, our results reveal that BPDE and other carcinogenic PAH diol epoxides acutely increase [Ca2+]i in SAE cells, untransformed human lung epithelial cells, inducing Ca2+ release from intracellular IP3-sensitive Ca2+ stores via IP3R-gated Ca2+ channels. The effects of carcinogenic PAH diol epoxides were proportional to their tumorigenicity observed in rodents. Moreover, prior short exposure of BPDE more than 36 h before the study attenuated the acute BPDE action on SAE [Ca2+]i, suggesting that even short-term exposure to BPDE may have long-lasting effects on SAE cell calcium homeostasis. Whether this observation has any implications for the carcinogenic effects of PAH exposure remains unknown. This experimental system may be valuable for determining BPDE action on initiation and progression of tumorigenesis in normal human lung cells in relation to its action on Ca2+-mediated intracellular signaling.
| |
Footnotes |
|---|
Address correspondence to: Harumi Jyonouchi, M.D., Dept. of Pediatrics, University of Minnesota, MMC 610, UMHC, 420 Delaware St. S. E., Minneapolis, MN 55455. E-mail: jyono001{at}tc.umn.edu
(Received in original form October 18, 2000 and in revised form February 14, 2001).
Abbreviations: 2-aminoethosydiphenyl borate, 2-APB; arylhydrocarbon receptor, AhR; anti-3,4-dihydroxy-1,2-epoxy-1,2,3,4-tetrahydrobenzo[c]phenanthrene, BcPDE; benzo[a]pyrene, BP; anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10- tetrahydrobenzo[a]pyrene, BPDE; cytosolic CA2+ concentration, [Ca2+]i; dimethyl sulfoxide, DMSO; extracellular regulated kinase, Erk; inositol 1,4,5-triphosphate receptor, InsP3R; anti-1,2-dihydroxy-3,4-epoxy-1,2,3,4-tetrahydro-5-methylchrysene, 5MeCDE; anti-1,2-dihydroxy-3,4-epoxy-1,2, 3,4-tetrahydro-6-methylchrysene, 6MeCDE; polycyclic aromatic hydrocarbon, PAH; small airway epithelial, SAE; xestospongin C, Xest C.
Acknowledgments:
This study was supported in part by RO1 HL60784 to one
author (D.N.C.) and a grant from Minnesota Medical Foundation to one author
(H.J.). The authors thank Dr. S. Hecht for his critical review of this manuscript.
| |
References |
|---|
|
|
|---|
1.
Conney, A. H..
1982.
Induction of microsomal enzyme by foreign chemicals
and carcinogenesis by polycyclic aromatic hydrocarbons.
Cancer Res.
42:
4875-4917
2. Conney, A. H., R. L. Chang, D. M. Jerina, and S. J. C. Wei. 1994. Studies on the metabolism of benzo[a]pyrene and dose-dependent differences in the mutagenic profile of its ultimate carcinogenic metabolite. Drug Metab. Rev. 21: 125-163 .
3.
Ross, J. A.,
G. B. Nelson,
K. H. Wilson,
J. R. Rabinowitz,
A. Galati,
G. D. Stoner,
S. Nesnow, and
M. J. Mass.
1995.
Adenomas induced by polycyclic
aromatic hydrocarbons in strain A/J mouse lung correlate with time-integrated DNA adduct levels.
Cancer Res.
55:
1039-1044
4. Dipple, A. 1994. Reactions of polycyclic aromatic hydrocarbons with DNA. In DNA Adducts: Identification and Biological Significance. K. Hemminki, A. Dipple, D. E. G. Shuker, F. F. Kadlubar, D. Segerbäck, and H. Bartsch, editors. International Agency for Research on Cancer, Lyon, France 125:107-129.
5.
Hecht, S. S..
1999.
Tobacco-smoke carcinogens and lung cancer.
J. Natl. Cancer Inst.
91:
1194-1210
6.
Preston, G. A.,
J. C. Barrett,
J. A. Biermann, and
E. Murphy.
1997.
Effects
of alterations in calcium homeostasis on apoptosis during neoplastic progression.
Cancer Res.
57:
537-542
7. Krieger, J. A., J. L. Born, and S. W. Burchiel. 1994. Persistence of calcium elevation in the HPB-ALL human T cell line correlates with immunosuppressive properties of polycyclic aromatic hydrocarbons. Toxicol. Appl. Pharmacol. 127: 268-274 [Medline].
8. Davila, D. R., D. P. Davis, K. Campbell, J. C. Cambier, L. A. Zigmond, and S. W. Burchiel. 1995. Role of alternations in Ca2+-associated signaling pathways in the immunotoxicity of polycyclic aromatic hydrocarbons. J. Toxicol. Environ. Health 45: 101-126 [Medline].
9. Krieger, J. A., D. R. Davilla, J. L. Lytton, J. L. Born, and S. W. Burchiel. 1993. Inhibition of sarcoplasmic/endoplasmic reticulum calcium-ATPase (SERCA) by polycyclic aromatic hydrocarbons in HPB-ALL human cells and other tissues. Toxicol. Appl. Pharmacol. 133: 102-108 .
10.
Tannheimer, S. L.,
S. L. Barton,
S. P. Ethier, and
S. W. Burchie.
1997.
Carcinogenic polycyclic aromatic hydrocarbons increase intracellular Ca2+ and
cell proliferation in primary human mammary epithelial cells.
Carcinogenesis
18:
1177-1182
11.
Jyonouchi, H.,
S. Sun,
K. Iijima,
M. Y. Wong, and
S. S. Hecht.
1999.
Effects
of anti-7,8-dihydroxy-9,10-epoxy-7,8,9,10-tetrahydrobenzo[a]pyrene on human small airway epithelial cells and the protective effects of myo-inositol.
Carcinogenesis
20:
139-145
12.
Grynkiewiz, G.,
M. Poenie, and
R. Y. Tsien.
1985.
A new generation of Ca2+
indicators with greatly improved fluorescence properties.
J. Biol. Chem.
260:
3440-3450
13. Tsien, R.Y. 1999. Monitoring cell calcium. In Calcium as a Cellular Regulator. E. Carafoli and C. Klee, editors. Oxford University Press, New York. 28-54.
14.
Hecht, S. S.,
S. Amin,
K. Huie,
A. A. Melikian, and
R. G. Harvey.
1987.
Enhancing effect of a bay region methyl group on tumorigenicity in newborn
mice and mouse skin of enantiomeric bay region diol epoxides formed stereoselectively from methylchrysens in mouse epidermis.
Cancer Res.
47:
5310-5315
15.
Hecht, S. S.,
K. EiBayoumy,
A. Rivenson, and
S. Armin.
1994.
Potent mammary carcinogenicity in female CD rats of a fjord region diol epoxide of
benzo[c]phenantheren compared to a bay region diol epoxide of benzo-
[a]pyrene.
Cancer Res.
54:
21-24
16.
Hecht, S. S.,
Z. A. Ronai,
L. Dolan,
D. Desai, and
S. Amin.
1998.
Comparative mouse skin tumorigenicity and induction of Ha-ras mutations by bay
region diol epoxides of 5-methylchrysene and 5,6-dimethylchrysene.
Carcinogenesis
19:
157-160
17. Giannini, G., and V. Correntiono. 1995. Molecular structure and tissue distribution of ryanodine calcium channels. Med. Res. Rev. 15: 313-323 [Medline].
18.
Ma, H. T.,
R. L. Patterson,
D. B. van Rossum,
L. Birnbaumer,
K. Mikoshiba, and
D. L. Gill.
2000.
Requirement of the inositol triphosphate receptor for
activation of store-operated Ca2+ channels.
Science
287:
1647-1651
19. Mikoshiba, K.. 1997. The InsP3 receptor and intracellular Ca2+ signaling. Curr. Opin. Neurobiol. 7: 339-345 [Medline].
20. Taylor, C. W.. 1998. Inositol triphosphate receptors: Ca2+-modulated intracellular Ca2+ channels. Biochim. Biophys. Acta 1436: 19-33 [Medline].
21. Yagi, H., D. R. Thakker, O. Hernandez, M. Koreeda, and D. M. Jerina. 1977. Synthesis and reactions of highly mutagenic 7,8,-diol-9,10-epoxides of the carcigenon benzo[a]pyrene. J. Am. Chem. Soc. 99: 1604-1611 [Medline].
22. Malkinson, A. M., and M. You. 1994. The intronic structure of cancer- related genes regulates susceptibility to cancer. Mol. Carcinog. 10: 61-65 [Medline].
23. Prahalad, A. K., J. A. Ross, G. B. Nelson, B. C. Roop, L. C. King, S. Newnow, and M. J. Mass. 1997. Dibenzo[a,l]pyrene-induced DNA adduction, tumorigenicity, and Ki-ras oncogene mutations in strain A/J mouse lung. Carcinogenesis 18: 955-963 .
24. Matzinger, S. A., B. Chen, Y. Wang, K. A. Crist, G. D. Stoner, G. J. Kelloff, R. A. Lubet, and M. You. 1997. Tissue-specific expression of the K-ras allele from the A/J parent in (A/J x TSG-p53) F1 mice. Gene 188: 261-269 [Medline].
25. Lopes-Ilasaca, M.. 1998. Signaling from G-protein-coupled receptors to mitogen activated protein (MAP)-kinase cascade. Biochem. Pharmacol. 56: 269-277 [Medline].
26. Williams, R . J. P. 1999. Calcium: the developing role of its chemistry in biological evolution. In Calcium as a Cellular Regulator. E. Carafoli and C. Klee, editors. Oxford University Press, New York. 3-27.
27.
Hunter, T..
2000.
Signaling
2000 and beyond.
Cell
100:
113-127
[Medline].
This article has been cited by other articles:
![]() |
A. D. Burdick, I. D. Ivnitski-Steele, F. T. Lauer, and S. W. Burchiel PYK2 mediates anti-apoptotic AKT signaling in response to benzo[a]pyrene diol epoxide in mammary epithelial cells Carcinogenesis, November 1, 2006; 27(11): 2331 - 2340. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ito, M. Son, S. Sato, T. Ohashi, M. Kondo, K. Shimokata, and H. Kume Effects of Fluoranthene, a Polycyclic Aromatic Hydrocarbon, on cAMP-Dependent Anion Secretion in Human Airway Epithelia J. Pharmacol. Exp. Ther., February 1, 2004; 308(2): 651 - 657. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Proc. Am. Thorac. Soc. | Am. J. Respir. Crit. Care Med. |